NCT05680311View on ClinicalTrials.gov

Autotaxin: a Potential Biomarker for Breast Cancer.

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

March 15, 2021

Conditions
Breast Cancer
Interventions
BIOLOGICAL

measurement of serum autotaxin serum level

autotaxin expression

Trial Locations (1)

06170

Ankara Etlik City Hospital, Ankara

All Listed Sponsors
collaborator

Diskapi Yildirim Beyazit Education and Research Hospital

OTHER_GOV

lead

Ankara Etlik City Hospital

OTHER_GOV

NCT05680311 - Autotaxin: a Potential Biomarker for Breast Cancer. | Biotech Hunter | Biotech Hunter